335810 — Precision Biosensor Cashflow Statement
0.000.00%
- KR₩49bn
- KR₩60bn
- KR₩20bn
Annual cashflow statement for Precision Biosensor, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -405 | -4,953 | -4,152 | -6,806 | -4,490 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | -1,834 | 3,666 | 527 | 3,407 | 1,180 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -593 | -4,373 | -2,128 | -1,459 | -1,788 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Net Change in Other Assets & Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -2,077 | -4,890 | -4,575 | -2,576 | -1,953 |
Capital Expenditures | -216 | -2,110 | -9,177 | -14,927 | -7,053 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -9,720 | 8,671 | -20,001 | 15,069 | -2,878 |
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -9,936 | 6,560 | -29,178 | 142 | -9,931 |
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 10,733 | 20,054 | 17,445 | 4,209 | 6,721 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -1,280 | 21,725 | -16,361 | 2,013 | -5,130 |